Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse

This case report describes the development of withdrawal from phenibut, a gamma-aminobutyric acid-receptor type B agonist. Although phenibut is not an FDA-approved medication, it is available through online retailers as a nootropic supplement. There are reports of dependence in patients that misuse...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Psychiatry
Hlavní autoři: Ahuja, Tania, Mgbako, Ofole, Katzman, Caroline, Grossman, Allison
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2018
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5952553/
https://ncbi.nlm.nih.gov/pubmed/29854531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9864285
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky